ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,646, issued on July 8, was assigned to MINERVA BIOTECHNOLOGIES Corp. (Waltham, Mass.).
"Diagnostic methods using anti-MUC1* antibodies" was invented by Cynthia Bamdad (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses a method of determining suitability of treating a patient suffering from cancer or metastasis of cancer characterized by aberrant expression of MUC1, with a MUC1* targeting therapeutic."
The patent was filed on March 21, 2024, under Application No. 18/612,767.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HIT...